Skip to content

The Effect of Hatha Yoga on Mental Health

A Comparison of Hatha Yoga and Mediation on Mental Health Outcomes.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05777044
Enrollment
45
Registered
2023-03-20
Start date
2022-09-09
Completion date
2023-08-01
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Mental Health Issue

Brief summary

The goal of this clinical trial is to determine the effects of a 10-week (2x a week; 45-minute per session) Hatha yoga intervention in adults ages 18-25 (n = 45) on mental health outcomes. The main questions it aims to answer are: What is the effect of a hatha yoga intervention on depression and anxiety symptoms? What is the effect of a hatha yoga intervention on electroencephalogram (EEG) alpha and theta band power? What is the effect of hatha yoga intervention on heart rate variability? Participants will be randomized to three groups: waitlist control (usual routine), Hatha yoga (experimental group), and meditation (active comparative group). Participants in the Hatha yoga experimental group will attend 10 weeks of twice-weekly 45-minute yoga sessions. The active comparison meditation group will participate in 10 weeks of twice-weekly 45-minute meditation sessions. The control group will continue with their usual routine. Researchers will compare changes in depression and anxiety symptoms, EEG alpha and theta band power, and heart rate variability between the three groups.

Detailed description

There are knowledge gaps that need to be addressed in understanding the effects of yoga, specifically long-term interventions, on physiological markers, electroencephalography (EEG) and heart rate variability (HRV) and elevated mental health symptoms in young adults. The present study will address the knowledge gaps by evaluating the effect of a 10-week (2x a week; 45-minute per session) Hatha yoga intervention in adults ages 18-25 (n = 45). Participants will be truly randomized to three groups: waitlist control (usual routine), Hatha yoga (experimental group), and meditation (active comparative group). This design will allow the investigators to determine the effects of Hatha yoga on relevant outcome measures. Changes in depression symptoms (BDI), anxiety symptoms (BAI), EEG alpha and theta band power, heart rate variability indices (RMSSD, LF/HF) will be assessed. Compared to the control group, investigators hypothesize that both the Hatha yoga and meditation groups will exhibit an improvement in depression and anxiety symptoms, an increased alpha and theta band power at rest, and an increased RMSSD and decreased LF/HF at rest. Moreover, the investigators hypothesize that the Hatha yoga group will improve body composition, flexibility, muscular endurance and strength, and cardiovascular recovery more than the meditation group.

Interventions

BEHAVIORALYoga

Participation in Hatha Yoga twice a week for 45 minutes for 10 weeks. The total potential dose is 900 minutes over the course of the intervention.

Sponsors

Auburn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Research personnel who administer heart rate variability and EEG were blinded to group assignment.

Intervention model description

Participants will be randomized to one of three groups: waitlist control (usual routine), Hatha yoga (experimental group), and meditation (active comparative group).

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18-35 * Medically healthy to participate in physical activity as determined by the Physical Activity Reading Questionnaire (PAR-Q) * Concerned about or experiencing heightened anxiety, depression, and/or stress symptoms

Exclusion criteria

* Those with diagnosed with an intellectual or developmental disability, currently diagnosed with a concussion, physically unhealthy to participate in physical activity * Anyone currently taking beta-blockers

Design outcomes

Primary

MeasureTime frameDescription
EEG10 weeksFrontal (F7/F8) and Temporoparietal (TP9/TP10) Alpha and Theta EEG power. 5-minute recording at rest; measured using the MUSE-2 system and Mind Monitor application.
Heart rate variability10 weeksRoot mean square of successive differences (RMSSD) and low-frequency/high-frequency ratio (LF/HF) indices of heart rate variability (HRV), 5-minute recording at rest; measured using the Polar H8/H9 HR monitors and HRVLogger application.
Depression10 weeksBeck's Depression Inventory (BDI) scores as measured by the Beck's Depression Inventory
Anxiety10 weeksBeck's Anxiety Inventory (BAI) scores as measured by the Beck's Anxiety Inventory

Secondary

MeasureTime frameDescription
Blood Pressure10 weeksResting blood pressure will be assessed with a automatic blood pressure cuff.
Aerobic capacity10 weeks3-minute YMCA step-test which will be an index of aerobic capacity
Body Fat Percentage10 weeks• Body Composition as measured by changes in body fat percentage (ratio of lean mass to fat mass)
Flexbility10 weeksChanges in shoulder and hamstring flexibility assessed with the Fitnessgram.
Muscular Endurance10 weeksChanges in push-up fitnessgram tests

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026